A liquid-liquid LC/MS/MS assay for the determination of artemether and DHA in malaria patient samples

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 2, 2011, Pages 373-378

  Wiesner, Lubbe ^a   Govender, Katya ^a   Meredith, Sandra A ^a   Norman, Jennifer ^a   Smith, Peter J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Antimalarial; Artemether; DHA; LC MS MS; Liquid liquid extraction; Method development and validation

Indexed keywords

ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; DIHYDROARTEMISININ; ISOTOPE; NEVIRAPINE;

ARTICLE; BLOOD SAMPLING; CALIBRATION; DRUG EFFICACY; DRUG ISOLATION; DRUG SAFETY; DRUG SCREENING; DRUG STABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALARIA; NONHUMAN; PLASMA; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ANTIMALARIALS; ARTEMISININS; CALIBRATION; HUMANS; MALARIA; REFERENCE STANDARDS; TANDEM MASS SPECTROMETRY;

EID: 79952246237     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.01.036     Document Type: Article

References (13)

1. World Health Organization, World Malaria Report 2008, http://apps.who.int/malaria/wmr2008/malaria2008.pdf.
2. Webster H.K., Lehnert E.K. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:S27-29.
3. Wernsdorfe W.H. Expert Rev. Anti-infect. Ther. 2004, 2:181-196. 10.1586/14787210.2.2.181.
4. Souppart C., Gauducheau N., Sandrenan N., Richard F. Development and validation of a high-performance liquid chromatography-mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasma. J. Chromatogr. B 2002, 774:195-203.
5. Peys E., Vandenkerckhove J., Van Hemel J., Sas B. Simultaneous determination of β-artemether and its metabolite dihydroartemisinin in human plasma and urine by a high-performance liquid chromatography-mass spectrometry assay using electrospray ionisation. Chromatographia 2005, 61:637-641.
6. Shi B., Yu Y., Li Z., Zhang L., Zhong Y., Su S., Liang S. Quantitative analysis of artemether and its metabolite dihydroartemisinin in human plasma by LC with tandem mass spectrometry. Chromatographia 2006, 64:523-530.
7. Magalhãesa I.R.S., Jabora V.A.P., Fariab A.M., Collins C.H., Jardimc I.C.S.F., Bonatoa P.S. Determination of β-artemether and its main metabolite dihydroartemisinin in plasma employing liquid-phase microextraction prior to liquid chromatographic-tandem mass spectrometric analysis. Talanta 2010, 81:941-947.
8. Xing J., Yan H., Wang R., Zhang L., Zhang S Liquid chromatography-tandem mass spectrometry assay for the quantitation of β-dihydroartemisinin in rat plasma. J. Chromatogr. B 2007, 852:202-207.
9. Lindegardh N., Hanpithakpong W., Kamanikom B., Singhasivanon P., Socheat D., Yi P., Dondorp A.M., McGready R., Nosten F., White N.J., Day N.P.J. Major pitfalls in the measurement of artemisinin derivatives in plasma in clinical studies. J. Chromatogr. B 2008, 876:54-60.
10. Huang L., Jayewardene A.L., Li X., Marzan F., Lizak P.S., Aweeka F.T. Development and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasma. J. Pharm. Biomed. Anal. 2009, 50:959-965.
11. Césara I.C., de Aquino Ribeiroa J.A., de Souza Teixeirab L., Belloriob K.B., de Abreub F.C., Moreirab J.M., Chellinia P.R., Pianettia G.A. Liquid chromatography-tandem mass spectrometry for the simultaneous quantitation of artemether and lumefantrine in human plasma: application for a pharmacokinetic study. J. Pharm. Biomed. Anal. 2011, 54:114-120.
12. Guidance for Industry Bioanalytical Method Validation 2001, Department of Health and Human Services, Food and Drug Administration, Rockville, USA.
13. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.